Showing 891-900 of 1768 results for "".
Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.AI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.Acquired Cutis Laxa: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/acquired-cutis-laxa-a-case-report/23653/Which Probiotic for Which Disease? Part 1
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.Tuberous Xanthomas in the Setting of Mild Dyslipidemia
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-tuberous-xanthomas-record-setting-match-day-dermatology-salaries-among-highest-for-specialties/22997/Natural Products that Exhibit Antifungal Activity
https://practicaldermatology.com/topics/general-topics/natural-products-that-exhibit-antifungal-activity/20360/Can natural products fight the fungus among us?Stevens-Johnson Syndrome: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/stevens-johnson-syndrome-a-case-series/23902/Successful treatment of drug-induced Stevens-Johnson Syndrome using cyclosporine and etanercept.Diagnosing and Managing Hair Disorders
https://practicaldermatology.com/topics/general-topics/diagnosing-and-managing-hair-disorders/20624/From loss to overgrowth, hair disorders may be associated with systemic causes.A Bold New Future for Psoriatic Arthritis Treatments in Dermatology
https://practicaldermatology.com/topics/psoriasis/a-bold-new-future-for-psoriatic-arthritis-treatments-in-dermatology/60989/The current therapeutic landscape highlights the dermatologist’s role in PsA management.Legalities of Injecting PDGF: Off-Label or Out-of-Bounds?
https://practicaldermatology.com/issues/october-2025/legalities-of-injecting-pdgf-off-label-or-out-of-bounds/39754/In medicine, science often moves faster than the rules designed to contain it do, and few debates illustrate this tension as starkly as the current one surrounding platelet-derived growth factor (PDGF) injections in aesthetic medicine.